FDA Inspection 1033939 — Mordechai R. Kramer, M.D.
The FDA completed an inspection of Mordechai R. Kramer, M.D. on Oct 26, 2017 in Tel-Aviv 49100. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 26, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tel-Aviv 49100 (Israel)
Additional Details
Clinical Investigator (CI)